Genotype-phenotype correlations in recessive RYR1-related myopathies
1 Department of Pediatrics, Taubman Medical Research Institute, University of Michigan Medical Center, 5019 A. Alfred Taubman Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109-2200, USA
2 Institute for Neuroscience and Muscle Research, Children’s Hospital at Westmead, University of Sydney, Level 3, Research Building Locked Bag 4001, Westmead, Sydney, NSW 2145, Australia
3 Department of Neuromuscular and Neurometabolic Disease, McMaster University Medical Center, Hamilton, Ontario, Canada
4 Neuromuscular and Neurogenetic Disorders of Childhood Section, National Institutes of Health, Bethesda, MD, USA
5 Division of Neurology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
6 Departments of Pediatrics and Neurology, University of Iowa, Carver College of Medicine, Iowa City, IA, USA
7 Department of Pediatric Neurology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA
8 Department of Neurology, Mayo Foundation for Medical Education and Research, Rochester, MN, USA
9 The Delta Pathology Group, Shreveport, LA, USA
10 Department of Neurology, University of Michigan Medical Center, Ann Arbor, MI, USA
11 Discipline of Paediatrics and Child Health, University of Sydney, Sydney, Australia
Orphanet Journal of Rare Diseases 2013, 8:117 doi:10.1186/1750-1172-8-117Published: 6 August 2013
RYR1 mutations are typically associated with core myopathies and are the most common overall cause of congenital myopathy. Dominant mutations are most often associated with central core disease and malignant hyperthermia, and genotype-phenotype patterns have emerged from the study of these mutations that have contributed to the understanding of disease pathogenesis. The recent availability of genetic testing for the entire RYR1 coding sequence has led to a dramatic expansion in the identification of recessive mutations in core myopathies and other congenital myopathies. To date, no clear patterns have been identified in these recessive mutations, though no systematic examination has yet been performed.
In this study, we investigated genotype-phenotype correlations in a large combined cohort of unpublished (n = 14) and previously reported (n = 92) recessive RYR1 cases.
Overall examination of this cohort revealed nearly 50% of cases to be non-core myopathy related. Our most significant finding was that hypomorphic mutations (mutations expected to diminish RyR1 expression) were enriched in patients with severe clinical phenotypes. We also determined that hypomorphic mutations were more likely to be encountered in non-central core myopathies. With analysis of the location of non-hypomorphic mutations, we found that missense mutations were generally enriched in the MH/CCD hotspots and specifically enriched in the selectivity filter of the channel pore.
These results support a hypothesis that loss of protein function is a key predictive disease parameter. In addition, they suggest that decreased RyR1 expression may dictate non-core related pathology though, data on protein expression was limited and should be confirmed in a larger cohort. Lastly, the results implicate abnormal ion conductance through the channel pore in the pathogenesis in recessive core myopathies. Overall, our findings represent a comprehensive analysis of genotype-phenotype associations in recessive RYR1-myopathies.